Economic evaluation of artesunate and three quinine regimens in the treatment of severe malaria in children at the Ebolowa Regional Hospital-Cameroon: a cost analysis.

ABSTRACT:

Background

Severe malaria is a leading cause of morbidity and mortality in under-fives in sub-Saharan Africa. Recently quinine has been replaced by artesunate as the first-line drug in the treatment of severe malaria in Cameroon. Artesunate has been shown to be cost-effective in African children, but whether these findings are transferable to Cameroonian children remains to be explored.

Objectives

To conduct a cost-analysis of four different regimens used in the treatment from the perspective of the healthcare payer.

Methods

An economic evaluation alongside a randomized comparative study was conducted in children aged 3 months to 15 years, admitted at the Ebolowa Regional Hospital with severe malaria due to Plasmodium falciparum. Patients were randomized to receive on

SUBMITTER: Maka DE 

PROVIDER: S-EPMC5142138 | biostudies-literature | 2016 Dec

REPOSITORIES: biostudies-literature